SA Phase III Clinical Study Shows SINOVAC Safe for Children as Young as 6 Months - Printable Version

+- SG Talk (https://sgtalk.net)
+-- Forum: SG Talk (https://sgtalk.net/Forum-SG-Talk)
+--- Forum: Market Talk (https://sgtalk.net/Forum-Market-Talk)
+--- Thread: SA Phase III Clinical Study Shows SINOVAC Safe for Children as Young as 6 Months (/Thread-SA-Phase-III-Clinical-Study-Shows-SINOVAC-Safe-for-Children-as-Young-as-6-Months)

---

SA Phase III Clinical Study Shows SINOVAC Safe for Children as Young as 6 Months - theold - 19-01-2022

On October 28, subjects aged 6 to 35 months were recruited in South Africa and 200 volunteers were successfully enrolled in the Phase III clinical trial on December 20. No Grade-3 or above adverse events were reported. As of December 22, nearly 4,000 children in South Africa have participated in the trial with zero reported severe adverse events.

This follows several countries – including Chile, Ecuador, El Salvador, Colombia, Cambodia and Indonesia – approving the use of the SINOVAC COVID-19 vaccine for children of varying ages since September.


On June 28, the Lancet Infectious Diseases online published the results of Phase I/II clinical studies of CoronaVac® in healthy children and adolescents aged 3 to 17 years in China with results showing good safety and tolerability, and a strong humoral immune response. 

On July 19, SINOVAC released the results of its world-first immunity persistence study of 180 individuals 3 to 17 years of age. It showed a 100% neutral antibody-positive conversion rate. The geometric mean titer (GMT) remained at a high level 28 days after the second dose, as well as another 3 months afterwards, which indicated that CoronaVac® induces stable and good immunogenicity.

http://www.sinovac.com/news/shownews.php?id=1365&lang=en

---

RE: SA Phase III Clinical Study Shows SINOVAC Safe for Children as Young as 6 Months - cityhantam - 19-01-2022

Good news!

---